3,3-Diaminobenzidine Tetrahydrochloride (DAB) Immunohistochemistry on Mouse Brain Tissue Sections

By Darren Moore and Madalynn Erb, PhD
View Published Protocol

Output Details

Description
This protocol details the staining for free floating mouse brain sections.
Identifier (DOI)
10.17504/protocols.io.3byl497zjgo5/v1
Tags
  • Animal models
  • Brain
  • Immunohistochemistry
  • In Vivo
  • Microscopy - optical
  • Mouse
Team
Team Lee
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

Related Research

Adult-Onset Deletion of ATP13A2 in Mice Induces Progressive Nigrostriatal Pathway Dopaminergic Degeneration and Lysosomal Abnormalities

Mutations in ATP13A2 gene can cause familial Parkinson's disease. Deleting ATP13A2 in adult mice leads to dopaminergic nerve terminal loss and neuronal degeneration, mimicking symptoms of ATP13A2-related neurodegenerative diseases.

View Article

Leveraging animal models to understand non-motor symptoms of Parkinson’s disease

Parkinson's disease diagnosis focuses on motor symptoms, but non-motor symptoms like cognitive issues and sleep disorders significantly affect patients. Research on non-motor signs in animals aims to improve understanding of the disease.

View Article

6-OHDA mouse model of Parkinson’s disease

Protocol for creating a Parkinson's disease mouse model using 6-OHDA involves injecting different doses into the brain to induce varying levels of dopaminergic damage.

View Protocol
View More Outputs